RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00059887.xml
CC BY 4.0 · Brazilian Journal of Oncology 2025; 21
DOI: 10.1055/s-0045-1807900
DOI: 10.1055/s-0045-1807900
ONCOGENETICS
1837
POSTER PRESENTATION
Germline testing recommendation (GTR) in non-small cell lung cancer (NSCLC) after broad tumor sequencing: evaluating the impact of more/less conservative criteria from ESMO/ASCO
Authors
Publikationsverlauf
Artikel online veröffentlicht:
06. Mai 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
Bibliographical Record
Breno Jeha Araújo, Rodrigo Dienstmann. Germline testing recommendation (GTR) in non-small cell lung cancer (NSCLC) after broad tumor sequencing: evaluating the impact of more/less conservative criteria from ESMO/ASCO. Brazilian Journal of Oncology 2025; 21.
DOI: 10.1055/s-0045-1807900
Breno Jeha Araújo, Rodrigo Dienstmann. Germline testing recommendation (GTR) in non-small cell lung cancer (NSCLC) after broad tumor sequencing: evaluating the impact of more/less conservative criteria from ESMO/ASCO. Brazilian Journal of Oncology 2025; 21.
DOI: 10.1055/s-0045-1807900